Cleared Traditional

K152516 - BD BBL Sensi-Disc Ceftazidime Avibactam...

K152516 is an FDA 510(k) clearance for BD BBL Sensi-Disc Ceftazidime Avibactam..., manufactured by Becton, Dickinson and Company. The device is a Class 2 Microbiology device with product code JTN cleared through the Traditional 510(k) pathway after a 40-day FDA review.

K152516 · Becton, Dickinson and Company · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2015
Decision
40d
Days
Class 2
Risk

K152516 is an FDA 510(k) clearance for the BD BBL Sensi-Disc Ceftazidime Avibactam (30/20ug), Antimicrobial Susceptibili.... Classified as Susceptibility Test Discs, Antimicrobial (product code JTN), Class II - Special Controls.

Submitted by Becton, Dickinson and Company (Sparks, US). The FDA issued a Cleared decision on October 13, 2015 after a review of 40 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1620 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Becton, Dickinson and Company devices

FDA 510(k) Submission Details - K152516

510(k) Number K152516 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 03, 2015
Decision Date October 13, 2015
Days to Decision 40 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 102d · This submission: 40d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JTN Device Classification - Class 2, Special Controls

Product Code JTN Susceptibility Test Discs, Antimicrobial
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JTN Susceptibility Test Discs, Antimicrobial

All 313
Devices cleared under the same product code (JTN) and FDA review panel - the closest regulatory comparables to K152516.
HardyDisk Ceftolozane/Tazobactam, (30/10 ug)-C/T40
K170127 · Hardy Diagnostics · Mar 2017
HardyDisk AST Ceftazidime/Avibactam, (30/20ug)-CZA50
K152838 · Hardy Diagnostics · Nov 2015
HardyDisk AST Ceftolozane/Tazobactam, (30/10ug)- C/T40
K152846 · Hardy Diagnostics · Nov 2015
HARDYDISK AST CEFTAROLINE, 30 UG MODEL Z939
K103538 · Hardy Diagnostics · Dec 2010
TELAVANCIN 30 UG, BBL SENSI-DISC
K100722 · Becton, Dickinson and Company · Mar 2010
HARDYDISK AST TELAVANCIN,30UG
K093807 · Hardy Diagnostics · Jan 2010